{"id":3644,"date":"2026-09-07T04:18:30","date_gmt":"2026-09-07T08:18:30","guid":{"rendered":"https:\/\/vr-news.net\/?p=3644"},"modified":"2026-09-07T04:18:30","modified_gmt":"2026-09-07T08:18:30","slug":"trumps-drug-pricing-deals-are-a-farce","status":"publish","type":"post","link":"https:\/\/vr-news.net\/?p=3644","title":{"rendered":"Trump\u2019s Drug Pricing Deals Are a Farce"},"content":{"rendered":"<div>\n<p>President Donald Trump is expected to <a href=\"https:\/\/www.bloomberg.com\/news\/articles\/2026-08-26\/white-house-to-announce-new-drug-pricing-deals-with-biotechs?accessToken=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzb3VyY2UiOiJTdWJzY3JpYmVyR2lmdGVkQXJ0aWNsZSIsImlhdCI6MTc4Nzc2MTU0MSwiZXhwIjoxNzg4MzY2MzQxLCJhcnRpY2xlSWQiOiJUSkNVRjRUOTZPU0swMCIsImJjb25uZWN0SWQiOiI2MkUxRTdCQjIyNzA0Mzk5QTBGNzRBRThCQ0I2QkZGMCJ9.9ptdcpRAH62mDNjmOzdWdG2DPvrSctn7mkIyJ2stVLU\" rel=\"noopener noreferrer\" target=\"_blank\">announce<\/a> more most-favored nation (MFN) drug pricing deals with additional pharmaceutical companies today. Public Citizen plans to immediately file a Freedom of Information request to obtain the texts of the newly claimed White House deals. <strong>Peter Maybarduk, Access to Medicines director for Public Citizen,<\/strong> issued the following statement:<\/p>\n<p>\u201cIt has been nearly a year since Trump<a href=\"https:\/\/www.whitehouse.gov\/fact-sheets\/2025\/09\/fact-sheet-president-donald-j-trump-announces-first-deal-to-bring-most-favored-nation-pricing-to-american-patients\/\" rel=\"noopener noreferrer\" target=\"_blank\"> announced his first<\/a> secret MFN deal with Pfizer, and he has almost nothing to show for it. The new deals are a distraction from the administration\u2019s failed plan to lower U.S. drug prices to the levels paid in other wealthy countries. A more serious approach would build international reference pricing into Medicare drug price negotiation. Instead, Trump is cozying up to Big Pharma and keeping American drug prices high.<\/p>\n<p>\u201cThere still is no evidence that any pharma company has followed through on prior commitments to the Trump administration to launch new drugs at MFN-price points. Uptake of TrumpRx, which may cause consumers to overpay on medicines, <a href=\"https:\/\/investors.goodrx.com\/static-files\/917181d9-f051-409d-be4b-736f9ce1ad19\" rel=\"noopener noreferrer\" target=\"_blank\">has been lackluster<\/a>. The Centers for Medicare and Medicaid Services (CMS) has not announced any state participants in a pilot to test MFN-based prices in Medicaid. And CMS has failed to issue final rules to test MFN-pricing in Medicare, while simultaneously <a href=\"https:\/\/www.statnews.com\/2026\/08\/05\/cms-drug-pricing-pilot-programs-rare-disease-drugs\/?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&amp;utm_medium=email&amp;_hsenc=p2ANqtz-9AXvM1Y-CuXfeukmQRst3w_cO9U8SvQudPapQEJQ-fzLCZY8GvnImGk0PKhyyCJmRDtuJ1VcmF81kw9g8Fm0ro_kY7hA&amp;_hsmi=431711214&amp;utm_content=431711214&amp;utm_source=hs_email\" rel=\"noopener noreferrer\" target=\"_blank\">excluding<\/a> almost all drug companies from these programs.\u201d<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>President Donald Trump is expected to announce more most-favored nation (MFN) drug pricing deals with additional pharmaceutical companies today. Public Citizen plans to immediately file a Freedom of Information request to obtain the texts of the newly claimed White House deals. Peter Maybarduk, Access to Medicines director for Public Citizen, issued the following statement: \u201cIt [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"registered_only","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[45],"tags":[742],"class_list":["post-3644","post","type-post","status-publish","format-standard","hentry","category-ciencia-y-tecnologia","tag-vr-news-net"],"_links":{"self":[{"href":"https:\/\/vr-news.net\/index.php?rest_route=\/wp\/v2\/posts\/3644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vr-news.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vr-news.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vr-news.net\/index.php?rest_route=\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/vr-news.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3644"}],"version-history":[{"count":0,"href":"https:\/\/vr-news.net\/index.php?rest_route=\/wp\/v2\/posts\/3644\/revisions"}],"wp:attachment":[{"href":"https:\/\/vr-news.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vr-news.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vr-news.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}